Uterine Fibroid Embolization

Uterine fibroid embolization (UFE) is a minimally invasive interventional radiology procedure used to treat symptomatic uterine fibroids by cutting off their blood supply. This page covers the clinical definition, procedural mechanism, common patient scenarios, and the decision boundaries that distinguish UFE from surgical alternatives. Understanding UFE within the broader landscape of interventional radiology procedures helps patients and clinicians weigh it against conventional options like myomectomy or hysterectomy.

Definition and scope

Uterine fibroids — formally termed uterine leiomyomas — are benign smooth muscle tumors of the uterus affecting an estimated 20% to 50% of women of reproductive age, according to the American College of Obstetricians and Gynecologists (ACOG). UFE is classified as a percutaneous, catheter-based embolization procedure performed by an interventional radiologist. Rather than surgically removing fibroids or the uterus itself, UFE selectively occludes the uterine arteries supplying fibroid tissue, causing infarction and shrinkage.

The procedure falls under the broader category of embolization techniques governed by standards from the Society of Interventional Radiology (SIR) and oversight frameworks described in the regulatory context for radiology, which covers FDA device approvals for embolic agents and fluoroscopic equipment. The embolic agents used — most commonly polyvinyl alcohol (PVA) particles or tris-acryl gelatin microspheres — are FDA-cleared devices, distinguishing UFE from experimental interventions. The Society of Interventional Radiology's Quality Improvement Guidelines for UFE establish minimum procedural standards for practitioners.

How it works

UFE proceeds through a standardized sequence of steps:

Pre-procedure imaging — MRI of the pelvis is performed to map fibroid number, size, location, and vascularity. MRI is preferred over ultrasound for procedural planning because it characterizes fibroid subtypes (submucosal, intramural, subserosal) with greater precision.
Arterial access — Under local anesthesia and moderate sedation, the interventional radiologist places a 4–5 French catheter through a small puncture in the radial or femoral artery.
Angiography — Contrast agent injection under fluoroscopy visualizes the uterine arterial anatomy and confirms feeding vessels to fibroid tissue.
Selective catheterization — The catheter is advanced into each uterine artery bilaterally. Embolic particles (typically 500–900 microns in diameter) are injected until flow to the fibroid is arrested.
Post-embolization angiography — Confirms devascularization of targeted fibroid tissue.
Closure and observation — The access site is closed; the patient is monitored, typically for 4 to 23 hours, before discharge.

Post-procedure fibroid volume reduction of 40% to 70% at 3 to 6 months is reported in peer-reviewed literature, including data published in the New England Journal of Medicine comparing UFE outcomes to hysterectomy at the 2-year mark. The uterus itself is preserved because the normal uterine myometrium receives collateral blood supply from ovarian and other pelvic vessels not targeted during the procedure.

Radiation exposure during UFE is a documented consideration. Fluoroscopy guidance involves cumulative dose that varies with procedure complexity; the radiologyauthority.com reference index situates UFE within the broader radiation dose framework covered at radiation dose and medical imaging.

Common scenarios

UFE is applied across a defined set of clinical presentations. The most frequently treated conditions include:

Menorrhagia — Heavy menstrual bleeding caused by submucosal or intramural fibroids, often resulting in iron-deficiency anemia
Bulk symptoms — Pelvic pressure, urinary frequency, or constipation produced by fibroids exceeding 5 cm in diameter
Dysmenorrhea — Fibroid-associated pelvic pain unresponsive to medical management
Fibroid-associated infertility — Selected cases where surgery carries unacceptable risk, though this remains a contested indication
Symptomatic pedunculated subserosal fibroids — Treated with caution given risk of detachment post-embolization

UFE is distinguished from uterine artery embolization (UAE) performed for postpartum hemorrhage. While the vascular technique is similar, the target pathology, embolic agent choice, and clinical goals differ fundamentally. Patients with pedunculated submucosal fibroids (type 0 by the FIGO leiomyoma subclassification system) are generally excluded because the risk of transcervical expulsion post-embolization is higher.

Decision boundaries

The choice between UFE and surgical alternatives — primarily myomectomy and hysterectomy — depends on four principal factors:

Fibroid characteristics — Fibroids larger than 10 cm in maximum diameter show lower rates of symptom resolution after UFE compared to smaller lesions. Fibroids with poor vascularity on pre-procedure MRI (suggesting degeneration) respond poorly to embolization.

Fertility intent — UFE is generally not the preferred treatment for patients seeking future pregnancy. ACOG guidance identifies myomectomy as the standard surgical option for fertility preservation. Published data on post-UFE pregnancy outcomes remain limited compared to myomectomy data.

Uterine preservation — Patients who wish to retain the uterus but are not candidates for surgery (due to comorbidities, prior abdominal operations, or anesthesia risk) represent a primary UFE candidate group.

Adenomyosis co-existence — When adenomyosis coexists with fibroids, UFE outcomes for bulk symptoms are less predictable. MRI differentiation of adenomyosis from intramural fibroids is a prerequisite for accurate patient selection.

Contraindications include active pelvic infection, known or suspected uterine malignancy, severe contrast allergy not amenable to premedication, and coagulopathy uncorrectable prior to the procedure. The interventional radiology fellowship training pathway covers case selection criteria as a core competency, reflecting the procedural judgment required at the decision boundary level.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)